Remove 2003 Remove Pharma Remove Safety
article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part i)

pharmaphorum

The present moment within and without healthcare, biotech, and pharma is a difficult and pivotal time in history, a time in which such issues need must be addressed. The keynote address of the event entire came from Stella Kyriakides, commissioner for health and food safety at the European Commission. Her opener?

article thumbnail

Market with Maximum Efficiency by Obeying Your Inner Sensei

PM360

Qualitative and quantitative research help pharma brand teams understand physician and patient attitudes, behaviors, and perspectives. For example, consider a pharma brand team trying to market its newest triple inhaler therapy for the treatment of COPD against its top competitor. Seize the Initiative.

article thumbnail

The Biotech Effect

Pharmaceutical Technology

However, a wave of exciting monoclonal antibody products was being developed, and these were quickly partnered with big pharma which demonstrated the increasing commercial opportunity for biotechnology. “There have been doubts about the extent to which the high prices paid by big pharmaceuticals were justified in the short term.”